Location History:
- 78350 Jouy en Josas, FR (1986)
- Gir-sur-Yvette, FR (2004)
- Elf sur Yvette, FR (2006)
- Gif-Sur-Yvette, FR (1999 - 2014)
Company Filing History:
32 out of 119 
6 out of 108 
4 out of 73 Years Active: 1986-2014
Areas of Expertise:
Title: Dennis Bigg - Innovator in Pharmaceutical Patents
Introduction
Dennis Bigg, based in Gif-sur-Yvette, France, is a prolific inventor with an impressive portfolio of 48 patents. His work primarily revolves around innovations in the pharmaceutical sector, focusing on compositions and derivatives that hold significant therapeutic potential.
Latest Patents
Among his most recent patents is a composition containing amidine derivatives or carboxamide derivatives combined with steroids, corticoids, or corticosteroids. This invention aims to provide a medicament formulation suitable for addressing various health conditions. Additionally, Dennis has developed novel imidazolidine-2,4-dione derivatives, which exhibit antiproliferative activity. These derivatives are particularly beneficial for treating diseases associated with abnormal cell proliferation, including cancers. His innovations also extend to pharmaceutical compositions that incorporate these novel compounds for medicinal use.
Career Highlights
Dennis Bigg has garnered substantial experience through his tenure at notable companies such as Société de Conseils de Recherches et d'Applications Scientifiques (SCRAS) and Ipsen Pharma S.A.S. His contributions in these organizations have been pivotal in advancing pharmaceutical research and development, particularly in the area of innovative medicaments.
Collaborations
Throughout his career, Dennis has collaborated with esteemed colleagues, including Serge Auvin and Anne-Marie Liberatore. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his research and development efforts.
Conclusion
Dennis Bigg's commitment to innovation in the field of pharmaceuticals has established him as a significant figure among inventors. His extensive patent portfolio reflects his dedication to addressing pressing health issues through groundbreaking research and development of new medicaments. As he continues to contribute to the field, his work will undoubtedly influence the future of therapeutic solutions.